Opinion|Videos|March 3, 2025
Key Takeaways on the Evolving Landscape of Pediatric Atopic Dermatitis Treatment
Panelists discuss the current treatment landscape for atopic dermatitis, noting significant advances in biologics and systemic therapies, and share optimism about the future of management, highlighting ongoing research and the potential for more targeted, personalized treatments to improve patient outcomes.
Advertisement
Episodes in this series
Video content above is prompted by the following:
Please share final thoughts on the current treatment landscape and future of atopic dermatitis management.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves gepotidacin as oral treatment for urogenital gonorrhea
2
FDA approves powder formulation of trofinetide for Rett syndrome
3
FDA approves berotralstat for patients aged 2 to 11 years with hereditary angioedema
4
Reports: FDA launching safety review of nirsevimab and clesrovimab for RSV
5
